Rehabilitating Overweight People Back to Working Life (ARRO)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Norwegian University of Science and Technology
ClinicalTrials.gov Identifier:
NCT01361490
First received: May 25, 2011
Last updated: September 4, 2014
Last verified: September 2014
  Purpose

Obesity may have implications on the individual's participation in working life through different mechanisms such as comorbidity and loss of functional level. The investigators also know that when exiting the working force, it is difficult to get back later. As rehabilitation back to working life is often not a very focused aim with weight loss treatment, this study sets this as a primary aim by involvement in a 4 week stay at a rehabilitation clinic followed by 48 weeks work practice programme at one of three different companies.


Condition
Obesity

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Rehabilitating Overweight People Back to Working Life

Further study details as provided by Norwegian University of Science and Technology:

Primary Outcome Measures:
  • Participation in working life [ Time Frame: 4 years ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Body weight [ Time Frame: 4 years ] [ Designated as safety issue: No ]

Enrollment: 405
Study Start Date: November 2010
Study Completion Date: May 2014
Primary Completion Date: November 2013 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   19 Years to 67 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Obese people where the obesity is the reason they are not actively taking part in working life.

Criteria

Inclusion Criteria:

  • BMI 30-47
  • 19-67 years

Exclusion Criteria:

  • Pregnancy
  • Significant reduced physical function
  • Drug use
  • Serious mental illness
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01361490

Locations
Norway
Muritunet Rehabiliteringssenter
Valldal, Norway
Sponsors and Collaborators
Norwegian University of Science and Technology
Investigators
Study Director: Bård Kulseng, phd prof Norwegian University of Science and Technology
  More Information

No publications provided

Responsible Party: Norwegian University of Science and Technology
ClinicalTrials.gov Identifier: NCT01361490     History of Changes
Other Study ID Numbers: RSSO 2010/3
Study First Received: May 25, 2011
Last Updated: September 4, 2014
Health Authority: Norway:National Committee for Medical and Health Research Ethics

Additional relevant MeSH terms:
Overweight
Body Weight
Signs and Symptoms

ClinicalTrials.gov processed this record on October 22, 2014